Bell Rock Capital’s AtriCure ATRC Stock Holding History

Bell Rock Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$26K	–	379
2019 Q1	$26K	Buy	+1,000	New	+$30.4K	0.01%	276

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bell Rock Capital's ATRC Position: Q2 2019 in Review

Bell Rock Capital sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 1,000 shares — an estimated $26K sold.

Bell Rock Capital first reported a position in ATRC in Q1 2019 and held it in 1 quarter. The position peaked at $26K in Q1 2019. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

Bell Rock Capital reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
Bell Rock Capital sold 1,000 AtriCure shares in Q2 2019, an estimated $26K.
Bell Rock Capital first reported a position in AtriCure in Q1 2019 and held it in 1 quarter.
Bell Rock Capital's AtriCure position peaked at $26K in Q1 2019.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Bell Rock Capital's 13F filing for Q2 2019, filed 31 Jul 2019.